Ozanne G, d'Halewyn M A, Larsen S A
Laboratoire de Santé Publique du Québec, Ste-Anne-de-Bellevue, Canada.
J Clin Microbiol. 1993 Jan;31(1):102-6. doi: 10.1128/jcm.31.1.102-106.1993.
A widely used immunoglobulin M (IgM) detection assay for the diagnosis of neonatal congenital syphilis is the fluorescent treponemal antibody absorption test used with fractionated serum (FTA-ABS 19S IgM test). Reading the results of the FTA-ABS test is more cumbersome than reading those of the FTA-ABS double staining (FTA-ABS-DS) test, a confirmatory test for specific IgG. To verify that the FTA-ABS-DS test used with an anti-human IgM conjugate could detect specific IgM in fractionated serum samples (FTA-ABS-DS 19S IgM test), 164 fractionated (QUIK-SEP IgM Isolation System; ISOLAB, Inc., Akron, Ohio) serum specimens from infected neonates or adults or from IgG-seronegative subjects were tested by both techniques. The sensitivity limits of the two tests were assessed with reactive serum samples diluted to an endpoint titer. Samples nonreactive by the FTA-ABS 19S IgM test (n = 74) were either nonreactive (n = 65), minimally reactive (n = 5), or reactive (n = 4) by the FTA-ABS-DS 19S IgM test. Samples minimally reactive by the FTA-ABS 19S IgM test (n = 32) were minimally reactive (n = 1) or reactive (n = 31) by the double staining test. All samples reactive by the FTA-ABS 19S IgM test (n = 58) were also reactive by the FTA-ABS-DS 19S IgM test. There was a directly proportional linear relationship (r = 0.9794) between titers obtained by both tests. FTA-ABS-DS 19S IgM titers were constantly equal to or higher than FTA-ABS 19S IgM titers. Fluorescence intensity reading repeatability was 91.4% for the FTA-ABS-DS 19S IgM test and 81.7% for the FTA-ABS 19S IgM test (P = 0.015). Because the more easily read FTA-ABS-DS 19S IgM test is at least as sensitive as, if not more sensitive than, the FTA-ABS 19S IgM test, it is a good alternative to the latter test for the detection of specific IgM in human fractionated sera for those using fluorescence microscopes with incident light.
一种广泛用于诊断新生儿先天性梅毒的免疫球蛋白M(IgM)检测方法是使用分馏血清的荧光密螺旋体抗体吸收试验(FTA-ABS 19S IgM试验)。读取FTA-ABS试验结果比读取FTA-ABS双重染色(FTA-ABS-DS)试验结果更麻烦,FTA-ABS-DS试验是一种针对特异性IgG的确诊试验。为了验证使用抗人IgM共轭物的FTA-ABS-DS试验能否检测分馏血清样本中的特异性IgM(FTA-ABS-DS 19S IgM试验),采用这两种技术对164份来自受感染新生儿、成人或IgG血清阴性受试者的分馏(QUIK-SEP IgM分离系统;ISOLAB公司,俄亥俄州阿克伦)血清标本进行了检测。用反应性血清样本稀释至终点滴度来评估两种试验的灵敏度极限。FTA-ABS 19S IgM试验无反应的样本(n = 74)在FTA-ABS-DS 19S IgM试验中要么无反应(n = 65)、反应微弱(n = 5),要么有反应(n = 4)。FTA-ABS 19S IgM试验反应微弱的样本(n = 32)在双重染色试验中反应微弱(n = 1)或有反应(n = 31)。FTA-ABS 19S IgM试验有反应的所有样本(n = 58)在FTA-ABS-DS 19S IgM试验中也有反应。两种试验获得的滴度之间存在直接成比例的线性关系(r = 0.9794)。FTA-ABS-DS 19S IgM滴度始终等于或高于FTA-ABS 19S IgM滴度。FTA-ABS-DS 19S IgM试验的荧光强度读数重复性为91.4%,FTA-ABS 19S IgM试验为81.7%(P = 0.015)。由于更易于读取结果的FTA-ABS-DS 19S IgM试验至少与FTA-ABS 19S IgM试验一样灵敏,甚至可能更灵敏,对于那些使用落射光荧光显微镜的人来说,它是检测人分馏血清中特异性IgM的FTA-ABS 19S IgM试验的一个很好的替代方法。